CNS pipeline · person
Mark Neumann, CPA
Executive Vice President and Chief Commercial Officer of Intra-Cellular Therapies since October 2018. Before joining the company he held leadership positions at Amgen (most recently Vice President, Global Marketing) and AstraZeneca, and spent more than two decades at Bristol Myers Squibb in commercial leadership roles. He is an inactive licensed CPA and earned his degree from Lafayette College.
- 1 company
Current roles
- Intra-Cellular Therapies, Inc.Executive Vice President, Chief Commercial Officer · Executive2018–present
Appears with
People sharing a company with Mark.
- E. Rene Salas · Intra-Cellular Therapies, Inc.
- Joel S. Marcus · Intra-Cellular Therapies, Inc.
- Lawrence J. Hineline · Intra-Cellular Therapies, Inc.
- Michael I. Halstead · Intra-Cellular Therapies, Inc.
- Robert L. Van Nostrand · Intra-Cellular Therapies, Inc.
- Rory B. Riggs · Intra-Cellular Therapies, Inc.
- Sharon Mates · Intra-Cellular Therapies, Inc.
- Suresh Durgam · Intra-Cellular Therapies, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.